AU2001259631A1 - Methods and vectors for generating antibodies in avian species and uses therefor - Google Patents
Methods and vectors for generating antibodies in avian species and uses thereforInfo
- Publication number
- AU2001259631A1 AU2001259631A1 AU2001259631A AU5963101A AU2001259631A1 AU 2001259631 A1 AU2001259631 A1 AU 2001259631A1 AU 2001259631 A AU2001259631 A AU 2001259631A AU 5963101 A AU5963101 A AU 5963101A AU 2001259631 A1 AU2001259631 A1 AU 2001259631A1
- Authority
- AU
- Australia
- Prior art keywords
- vectors
- methods
- avian species
- generating antibodies
- uses therefor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000271566 Aves Species 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/20—Heterogeneous data integration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Evolutionary Biology (AREA)
- Immunology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioethics (AREA)
- Databases & Information Systems (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20489900P | 2000-05-16 | 2000-05-16 | |
| US60/204,899 | 2000-05-16 | ||
| US09/573,442 US6951742B1 (en) | 1998-11-16 | 2000-05-16 | Methods and vectors for generating antibodies in avian species and uses therefor |
| US09/573,442 | 2000-05-16 | ||
| PCT/US2001/014817 WO2001088162A2 (en) | 2000-05-16 | 2001-05-07 | Methods and vectors for generating antibodies in avian species and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001259631A1 true AU2001259631A1 (en) | 2001-11-26 |
Family
ID=26899888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001259631A Abandoned AU2001259631A1 (en) | 2000-05-16 | 2001-05-07 | Methods and vectors for generating antibodies in avian species and uses therefor |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001259631A1 (en) |
| WO (1) | WO2001088162A2 (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002359913A1 (en) * | 2001-12-20 | 2003-07-09 | Agricultural Research Council | Semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes |
| CN1818651B (en) * | 2006-03-13 | 2010-07-21 | 东北农业大学 | Rabbit Anti-Goose IgY+IgY(△Fc)(H+L) Horseradish Peroxidase Labeled Antibody |
| CN102137928A (en) * | 2008-08-29 | 2011-07-27 | 西福根有限公司 | Methods for Cloning Antibodies of Avian Origin |
| EP3255146B1 (en) | 2009-03-16 | 2019-05-15 | Pangu Biopharma Limited | Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| US20100310576A1 (en) | 2009-03-31 | 2010-12-09 | Adams Ryan A | COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES |
| AU2011248625B2 (en) | 2010-04-26 | 2017-01-05 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase |
| JP6294074B2 (en) | 2010-04-27 | 2018-03-14 | エータイアー ファーマ, インコーポレイテッド | Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of isoleucyl-tRNA synthetase |
| AU2011248489B2 (en) | 2010-04-28 | 2016-10-06 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl tRNA synthetases |
| CN103118693B (en) | 2010-04-29 | 2017-05-03 | Atyr 医药公司 | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases |
| CA2797374C (en) | 2010-04-29 | 2021-02-16 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases |
| CA2800557A1 (en) | 2010-04-29 | 2011-11-03 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy |
| ES2668207T3 (en) | 2010-05-03 | 2018-05-17 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic and antibody compositions related to fragments of methionyl-tRNA synthetases proteins |
| EP2566515B1 (en) | 2010-05-03 | 2017-08-02 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases |
| AU2011248227B2 (en) | 2010-05-03 | 2016-12-01 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
| US9062302B2 (en) | 2010-05-04 | 2015-06-23 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex |
| US8945541B2 (en) | 2010-05-14 | 2015-02-03 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases |
| JP6027965B2 (en) | 2010-05-17 | 2016-11-16 | エータイアー ファーマ, インコーポレイテッド | Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of leucyl-tRNA synthetase |
| CN103096913B (en) | 2010-05-27 | 2017-07-18 | Atyr 医药公司 | Treatment, diagnosis and the innovation of antibody compositions related to the protein fragments of glutaminyl tRNA synzyme is found |
| US8962560B2 (en) | 2010-06-01 | 2015-02-24 | Atyr Pharma Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases |
| WO2012021247A2 (en) | 2010-07-12 | 2012-02-16 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
| JP5964304B2 (en) | 2010-08-25 | 2016-08-03 | エータイアー ファーマ, インコーポレイテッド | Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of tyrosyl-tRNA synthetase |
| US20140106986A1 (en) | 2011-06-01 | 2014-04-17 | Medical Prognosis Institute A/S | Methods and devices for prognosis of cancer relapse |
| CN104334196B (en) | 2012-02-16 | 2018-04-10 | Atyr 医药公司 | For treating the Histidyl-tRNA-synthetase of autoimmune disease and inflammatory disease |
| CN104937111B (en) | 2012-11-27 | 2018-05-11 | 智利天主教教皇大学 | For diagnosing the composition and method of thyroid tumors |
| US10392667B2 (en) | 2013-06-07 | 2019-08-27 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients |
| EP3169815B1 (en) | 2014-07-15 | 2020-12-23 | Ontario Institute For Cancer Research | Methods and devices for predicting anthracycline treatment efficacy |
| GB2579856A (en) * | 2018-12-18 | 2020-07-08 | Emergex Vaccines Holding Ltd | MHC Class I associated peptides for prevention and treatment of hepatitis B virus infection |
| WO2021205408A1 (en) * | 2020-04-10 | 2021-10-14 | Igy Immune Technologies And Life Sciences Inc. | Igy immunoglobulins targeting coronavirus, methods of preparing same, and methods of using same |
| CN117821469B (en) * | 2023-11-22 | 2024-08-02 | 扬州大学 | Application of chicken TRIM45 truncated recombinant protein or polyclonal antibody thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0690912B1 (en) * | 1993-04-14 | 2008-03-05 | Commonwealth Scientific And Industrial Research Organisation | Recombinant avian adenovirus vector |
| CA2350111A1 (en) * | 1998-11-16 | 2000-05-25 | Genway Biotech, Inc. | Generation of antibodies using polynucleotide vaccination in avian species |
-
2001
- 2001-05-07 AU AU2001259631A patent/AU2001259631A1/en not_active Abandoned
- 2001-05-07 WO PCT/US2001/014817 patent/WO2001088162A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001088162A3 (en) | 2002-09-19 |
| WO2001088162A2 (en) | 2001-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001259631A1 (en) | Methods and vectors for generating antibodies in avian species and uses therefor | |
| AU2002233938A1 (en) | Method and apparatus for protein manipulation | |
| IL149029A0 (en) | High mannose proteins and methods for producing the same | |
| AU4761601A (en) | Multivalent antibodies and uses therefor | |
| AU2002220843A1 (en) | Humanised antibodies and uses thereof | |
| GB0015426D0 (en) | Method for generating soluble highly multimeric proteins | |
| AU2001292867A1 (en) | Ligands for g protein coupled receptors and methods of using them | |
| AU2001236716A1 (en) | Antigenic complexes and methods | |
| AU2002221796A1 (en) | Hair clip and method for using said hair clip | |
| IL138946A0 (en) | Method for the identification of peptides and proteins | |
| AU2002365269A8 (en) | Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses | |
| EP1330535A4 (en) | Kini-3 motor protein and methods for its use | |
| EP1305331A4 (en) | Motor proteins and methods for their use | |
| AU4974299A (en) | Methods and constructs for protein expression | |
| AU2002243285A1 (en) | Auxiliary metering apparatus and methods | |
| AU2002341828A1 (en) | Enhanced proteins and methods for their use | |
| EP1294738A4 (en) | Novel motor proteins and methods for their use | |
| AU2001283207A1 (en) | Novel motor proteins and methods for their use | |
| AU2001261534A1 (en) | The meca-79 antigen and related methods | |
| AU2002213954A1 (en) | Method for the selective modification of peptides and proteins | |
| TWI318641B (en) | Methods and vectors for generating antibodies in avian species and uses therefor | |
| AU2002256556A1 (en) | Sea-trosy and related methods | |
| AU2001297707A1 (en) | Motor proteins and methods for their use | |
| AU2001250585A1 (en) | Insecticidal peptides and methods for using same | |
| EP1290151A4 (en) | Novel motor proteins and methods for their use |